EN
HI
Divi's Laboratories Share price
DIVISLAB
8440
160.00 (-1.86%)NSE
BSE
Last updated on 13 Aug, 2026 | 15:11 IST
Divi's Laboratories share price chart
Divi's Laboratories Share Key Metrics
Volume
3.30 L
Market Cap
228302.98 CR
LTQ@LTP
19@8440.00
ATP
8450.9
Var Margin
13.43 %
Circuit Range
7740-9460
Delivery %
64.42 %
Value
278.81 CR
ASM/GSM
No
Market Lot
1
Summary
DIVISLAB stock price is ₹8440 as of 13 Aug, 2026. The stock intraday movement has stayed between ₹8414.00 and ₹8539.50, while Divi's Laboratories share price 52 week high low is ₹5636.50 & ₹8674.00.
In terms of trading activity, DIVISLAB share price has recorded a volume of 3,29,914 shares. The Divi's Laboratories has a market cap of ₹265468580. The stock’s Average Traded Price (ATP) stands at ₹8450.90, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 19 @ ₹8440.00.
The Divi's Laboratories upper circuit limit is ₹9460.00 & The Divi's Laboratories lower circuit limit is ₹7740.00, with a Value of ₹278.81 CR. The Delivery Percentage for the day is 64.42%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Divi's Laboratories Resistance and Support
Pivot 8581.83
Resistance
First Resistance
8692.16
Second Resistance
8784.33
Third Resistance
8894.66
Support
First Support
8489.66
Second Support
8379.33
Third Support
8287.16
Divi's Laboratories Futures & Options
8440
-160 (-1.86%)
Divi's Laboratories Option Chain
View Price, OI, Greeks & More...
25AUG26
8474.50
-12.50 (0.15%)
29SEP26
8527.00
-14.50 (0.17%)
27OCT26
8580.00
-7.00 (0.08%)
DIVISLAB|25AUG26 CE 8400.00
182.40
-28.35 (-13.45%)
DIVISLAB|25AUG26 PE 8500.00
150.75
-15.45 (-9.3%)
Divi's Laboratories Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
51.89%
Mutual Fund
11.89%
Insurance
7.66%
Foreign Institutional Investors
17.98%
Domestic Institutional Investors
1%
Retail
9.59%
Others
-0.01%
Total Promoters
MAR '24
51.92%
JUN '24
51.9%
SEP '24
51.89%
DEC '24
51.89%
Divi's Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-01 | Quarterly Results |
| 2026-05-23 | Audited Results & Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-06 | Quarterly Results |
| 2025-05-17 | Audited Results & Dividend |
| 2025-02-03 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-03 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-24 | 2026-07-24 | View More |
Divi's Laboratories News
Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Divi's Laboratories Limited has made the audio recording of its Q1 FY27 earnings conference call available on its website. This recording covers the financial performance for the quarter ended June 30, 2026.
Aug 01 2026 15:52:22
Divis Laboratories Ltd - 532488 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 01, 2026.
Divi's Laboratories reported Q1 FY27 cons. total income of ₹3,144 cr, up 24.3% YoY, and PAT of ₹902 cr, up 65.5% YoY. The company also appointed Mr. B. Vara Prasad and Mr. J. Srinivasa Rao as Senior Management Personnel, effective August 1, 2026.
Aug 01 2026 11:35:47
Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Divis Labs will host an earnings conference call on August 1, 2026, at 2:00 PM IST. The call will discuss the company's unaudited financial results for the first quarter of FY27, ended June 30, 2026.
Jul 24 2026 10:29:45
Read More
Divi's Laboratories Management
| Name | Position |
|---|---|
| M Satish Choudhury | Company Secretary & Compliance Officer |
| Murali K Divi | Managing Director |
Divi's Laboratories Similar Stocks
Sun Pharmaceutical Industries Ltd.
1936.80
-7.20 (0.37%)
Torrent Pharmaceuticals Ltd.
4868.50
-24.50 (0.50%)
Apollo Hospitals Enterprise Ltd.
8594.00
-3.00 (0.03%)
Cipla Ltd.
1459.80
-3.20 (0.22%)
Zydus Lifesciences Ltd.
1172.10
-32.90 (2.73%)
Lupin Ltd.
2257.00
-24.00 (1.05%)
Lenskart Solutions Ltd.
599.60
13.15 (2.24%)
Max Healthcare Institute Ltd.
1009.00
1.50 (0.15%)
Dr. Reddy's Laboratories Ltd.
1205.60
5.60 (0.47%)
Laurus Labs Ltd.
1841.80
-8.20 (0.44%)
Divi's Laboratories FAQs
The Buying Price of Divi's Laboratories share is 8440 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Divi's Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Divi's Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Divi's Laboratories shares is 77.55. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Divi's Laboratories shares is 12.84. Useful to assess the stock's value relative to its book value.
To assess Divi's Laboratories’s valuation compare Sector P/E, P/B which are 64.16 & 3.28 with sector averages, along with growth rates and financial metrics.
The Market Cap of Divi's Laboratories is 228302.98 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Divi's Laboratories share price is 8674.00 & 5636.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Divi's Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Invest in DIVISLAB
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC